Condition Guide
Peptides for Fatty Liver Disease (MASH / NAFLD)
Metabolic dysfunction-associated steatohepatitis (MASH, formerly NASH) is an emerging target for incretin-based peptide therapy. Semaglutide, tirzepatide, and retatrutide all demonstrate meaningful reductions in hepatic fat.
Educational content only. This page is compiled from published research for reference and is not medical advice, diagnosis, or treatment. Readers should verify claims against primary sources and consult a qualified healthcare provider before making any health decisions. Full disclaimer.
How peptides help
Incretin agonists reduce liver fat through weight loss, improved insulin sensitivity, and direct hepatic effects. Triple agonists with glucagon receptor activity may be particularly effective due to glucagon-mediated lipid oxidation.
Peptides researched for fatty liver disease (mash / nafld)
Semaglutide
Moderate EvidenceL5Phase II data shows MASH resolution.
630 studies · GLP-1 Receptor Agonism
Tirzepatide
Moderate EvidenceL5SYNERGY-NASH showed significant MASH resolution.
180 studies · Dual GIP/GLP-1 Agonism
Retatrutide
Moderate EvidenceL4Phase II ~80% MASH resolution; best-in-class liver fat reduction.
31 studies · Triple GIP/GLP-1/Glucagon Agonism
State of the evidence
Semaglutide has Phase II MASH data showing resolution of steatohepatitis. Retatrutide Phase II showed ~80% MASH resolution. Phase III trials ongoing.
Frequently asked
Can GLP-1 agonists reverse fatty liver?
Yes — trial data shows significant reductions in hepatic fat content and inflammation with GLP-1, dual, and triple agonists. Some patients achieve complete resolution of steatohepatitis.
Related articles & guides
What Are Peptides? A Science-Based Introduction
Guide · 12 min
Peptides for Weight Loss: What the Research Shows
Guide · 15 min
FDA Regulation of Peptides: What You Need to Know
Guide · 10 min
Natural Alternatives to Ozempic: Do Any Peptides or Supplements Actually Work?
Analysis · 12 min
How to Inject Peptides: A Complete Beginner's Guide to Subcutaneous Injections
Learn · 14 min
Stanford Discovers "Natural Ozempic" Peptide That Cuts Appetite 50% Without GI Side Effects
Research · 9 min
New Study: Tirzepatide Causes More Muscle Loss Than Semaglutide in 8,000-Patient Analysis
Research · 8 min
Semaglutide Fails Alzheimer's Trial: What the EVOKE Results Mean for GLP-1 Brain Claims
Research · 10 min
Tirzepatide for Weight Loss: What the Clinical Trials Actually Show
Deep Dive · 13 min
Related conditions
Type 2 Diabetes
Incretin-based peptides improve glycemic control, reduce HbA1c, and provide cardiovascular benefits.
Weight Loss
Peptides that reduce appetite, slow gastric emptying, and improve metabolic health for sustained weight loss.
Metabolic Syndrome
Incretin and mitochondrial peptides improve insulin sensitivity, blood pressure, and lipid profile.